Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Type I interferons (IFN-I) are critical for antiviral immunity; however, chronic IFN-I signaling is associated with hyperimmune activation and disease progression in persistent infections. We demonstrated in mice that blockade of IFN-I signaling diminished chronic immune activation and immune suppression, restored lymphoid tissue architecture, and increased immune parameters associated with control of virus replication, ultimately facilitating clearance of the persistent infection. The accelerated control of persistent infection induced by blocking IFN-I signaling required CD4 T cells and was associated with enhanced IFN-γ production. Thus, we demonstrated that interfering with chronic IFN-I signaling during persistent infection redirects the immune environment to enable control of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, during viral infections, chronic type I and II IFN signaling can lead to immune suppression and a failure to clear viral infection.51-53”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Du Pasquier, R. A., Romero, P., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 933
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Self-citationInterferon signaling and treatment outcome in chronic hepatitis C
Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H. T., Christen, V., Terracciano, L., Filipowicz, W., & Heim, M. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707882105 · Cited by 642
Resolution of a chronic viral infection after interleukin-10 receptor blockade
Ejrnaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S., & von Herrath, M. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061462 · Cited by 548
Jacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., Dillies, M.-A., Roques, P., Butor, C., Silvestri, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40093 · Cited by 481
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W., & Levy, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.011 · Cited by 470
Pathogenic Mechanisms of HIV Disease
Moir, S., Chun, T.-W., & Fauci, A. S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130254 · Cited by 463
Research works printed but not linked: 2
- Brockman MA Blood 2009 114 346 19365081 PMC2714209 · DOI · Paper page
- 10.1089/jir.2012.0037 · DOI
Cited by
Items 701–713 of 713
TopicVI: A Knowledge-guided deep interpretable model for resolving context-specific gene programsPreprint
Cai, G., Zhao, W., Zhu, X., Lin, Y., Zhou, B., Cao, J., He, Q. P., Yang, B., Gu, X., Xiong, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.08.717220
“Notably, existing research highlights the critical role of interferon in CD4 + T cell differentiation and maturation 31,32 , where it promotes their activation and differentiation into T-helper cells.”
Dawood, A. S., Wolfson, E. E., Jiwani, S., Ozdilek, A., Zohdy, Y. M., Gourdine, T., Rahman, S. A., Tomalka, J. A., & Abdel-Hakeem, M. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.28.721334
Dai, X., Hua, S., Xue, L., Gong, Z., Ya-ying, P., Li, Z., Han, C., Gao, X.-M., & Gong, F. (2026) · Journal of Virology · doi:10.1128/jvi.02106-25
Jump-starting the T cell response in established tumorsPreprint
McCaw, T. R., Liu, M., Scharer, C. D., Boss, J. M., Mi, T., Rosenberg, A. F., Li, M., Arend, R. C., Buchsbaum, D. J., Markert, J. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.28.728503
Rios-Vazquez, V., Delporte, M., Otten, T., Matzaraki, V., Vos, W. A. J. W., Blaauw, M. J. T., van Eekeren, L. E., Groenendijk, A. L., Knoll, R., Aschenbrenner, A. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.24.734029
Differential stem-like potential of naïve and memory CD8 T cells after chronic infection
Lee, K., Lee, J., Ahmed, R., & Im, S. J. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag164
Macrophage responses to and elevated antibody levels against Chlorovirus ATCV-1 in ALS patients
Petro, T. M., Pattee, G. L., Esmael, A., Agarkova, I. V., Dunigan, D. D., Chiodo, F., Castro, C. D., & Etten, J. L. V. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106491
Cao, Y., Zhao, C., Liang, Y., Li, X., Zhang, Z., Yang, Q., & Shao, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1894437
“The fourth is metabolic and cytokine context: hypoxia, type I interferons, IL-10, TGF-b , adenosine, indoleamine 2,3-dioxygenase, and chronic antigen load can reinforce check-point-driven dysfunction (38, 39).”
T cell exhaustion in cancer: from functional decline to adaptive immune regulation
Wang, Y., Yu, Y., Zhuang, J., Liu, R., & Sun, C. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02767-7
Zhang, K., Chen, Y., Ran, L., Tong, W., Dai, L., Yang, Z., Chen, Q., Zheng, J., & Hu, G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1857676
“…research has shown that in chronic viral infections, Clec12a can contribute to the amplification of type I interferon (IFN-I) signaling through the Src–TBK1–IRF3 pathway, which aggravates chronic immunopathology in which inhibition would be effective (Wilson et al., 2013; Li K. et al., 2019).”
Interferons and STAT1 dynamically modulate integrated stress response outcomes in CD8 T cellsPreprint
Philips, R. L., Yu, K., Liao, Y.-C., Jung, S., Jiang, K., Kanno, Y., Randazzo, D., Oakes, S. A., & O’Shea, J. J. (2026) · Research Square · doi:10.21203/rs.3.rs-10692330/v1
“Despite IFNs positive effect on lymphocyte activation, chronic IFN suppresses CD8 + T cell activity 5,6 .”
The Role of Heterologous Immunity in Viral Co-Infections and Neonatal Immunity: A Dissertation
Kenney, L. L. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2c31z
“Furthermore the induction of type I IFN has recently been linked with the clonal exhaustion found during LCMV clone 13 infection (Teijaro et al., 2013; Wilson et al., 2013).”
BackgroundInfluentialType I interferons and T regulatory cells : effects on development, homeostasis and function
Metidji, A. (2015) · theses.fr (ABES) · doi:10.70675/757ff6f0z8580z46a2z855ez382e0943c383
“Lastly, two recent studies have demonstrated that inhibition of IFNAR signaling either genetically or by antibody blockade in chronic infection with LCMV led to a substantial reduction in virus titers and enhanced anti-viral CD4 T cell responses (209, 210).”
Background
Metadata
- Authors
- Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., & Brooks, D. G.
- Affiliations
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Brooks, David G.
- ORCID
- Venue
- Science
- Published
- 2013-04-12
- Volume
- 340
- Issue
- 6129
- Pages
- 202-207
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3704950
- OpenAlex
- W2049868800
- Cited by
- 709
- References
- 29
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 34 · 2023: 35 · 2022: 35 · 2021: 48 · 2020: 50 · 2019: 50 · 2018: 58 · 2017: 72 · 2016: 87 · 2015: 72 · 2014: 70 · 2013: 34
- FWCI
- 48.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000077)
- National Heart, Lung, and Blood Institute (R01HL108949, HL108949)
- National Institute of Allergy and Infectious Diseases (AI060567, T32AI060567, U01AI082975, R01AI085043, AI082975, R01AI056154, AI085043, R01AI047868, P30AI028697)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50AR063020)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- type I interferon signaling, chronic infection, lymphocytic choriomeningitis virus, viral persistence, immune activation, immunosuppression, CD4+ T cells, interferon-gamma, antiviral immunity, viral clearance
- MeSH terms
- Animals, Antibodies, Arenaviridae Infections, Dendritic Cells, Immune Tolerance, Interferon Type I, Interferon-gamma, Lymphocytic choriomeningitis virus, Virus Replication, Signal Transduction, CD4-Positive T-Lymphocytes, Cytokines, Interleukin-10, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice, Receptor, Interferon alpha-beta, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.